Dr. Baliga's 'Podkasts for Curious Docs'
๐ Immune checkpoint inhibitors have transformed cancer careโbut they come with a cardiovascular shadow. A new International Cardio-Oncology Society (IC-OS) position statement offers the clearest guidance yet on myocarditis, pericarditis, arrhythmias, ACS, and noninflammatory HF linked to ICI therapy. ๐ซ๐ก Key insights include: โข Early recognition with troponin, ECG, and CMR ๐งช๐ โข Smoldering vs. nonsevere vs. fulminant myocarditis distinctions ๐ โข Steroid-first management and the evolving role of abatacept + JAK inhibitors ๐ โข Nuanced approaches to ICI...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
Chronic kidney disease now affects nearly 850 million people worldwide, yet early detection and simple, evidence-based interventions can dramatically change the trajectory of both kidney and cardiovascular health. ๐๐ฉบ The latest Lancet Seminar highlights powerful toolsโeGFR + albuminuria staging, SGLT2 inhibitors, RAS blockade, statins, and GLP-1 therapiesโthat allow every clinician to make a measurable impact. ๐๐ A reminder that timely action is kidney protection. ๐งโจ
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
๐ New insights from Cell shine a light on an unexpected ally in the fight against cognitive decline. A natural experiment from Wales shows that the shingles (herpes zoster) vaccine doesnโt just prevent viral reactivationโit may also reduce new mild cognitive impairment and lower dementia-related mortality over long-term follow-up. ๐ Using a strict birthday-based eligibility cutoff, the study provides causal evidenceโrare in population dementia researchโthat vaccination may slow disease across its entire course. ๐ง โจ As we rethink neuroinflammation, immunosenescence, and...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
๐ New NEJM Evidence for the 2025โ26 Vaccine Season is outโand it delivers clarity at a time we need it most. The systematic review of 511 studies shows strong, consistent protection against hospitalization from Covid-19, RSV, and Influenza, with reassuring safety profiles across age groups. ๐๐ก๏ธ Key insights: improved VE for updated Covid-19 strains, high efficacy of maternal RSV vaccination and nirsevimab for infants, and solid influenza performance. ๐๐ถ A valuable guide for clinicians, health systems, and policymakers as we prepare for the upcoming...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
New Lancet Seminar on heart failure with reduced ejection fraction. ๐๐, this videocast walks listeners through the essentials of diagnosis, natriuretic peptides, imaging pathways, and the four foundational therapies shaping modern heart failure care. Itโs a clear, evidence-driven journeyโdesigned to inform, clarify, and elevate bedside practice. Tune in to explore the science, the strategy, and the future of treating HFrEF. ๐ซ๐ฌโจ ๐ซ๐ฌโจ
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
๐๐ Chronic Coronary Artery Disease: Seeing What Matters Before It Hurts Just finished reviewing the 2025 Lancet paper on contemporary non-invasive imaging for chronic CAD, and the message is striking: how we see the heart shapes how well we save it. From CT angiography that unmasks non-obstructive plaque ๐ฅ๏ธโก๏ธ๐ซ to stress PET/CMR that maps true ischemia under load ๐จ๐, multimodality imaging is redefining diagnosis, risk, and long-term outcomes. The evidence is clear: better imaging leads to better preventionโand in many cases, fewer invasive...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
Exploring David Hume ๐ง โจ Just revisited David Humeโs extraordinary contributions to modern thought โ a reminder of how deeply empiricism, skepticism, and the science of human nature shape our intellectual world. His insights on causation, the limits of reason, and the power of moral sentiment continue to resonate across philosophy, psychology, economics, and evidence-based decision-making. ๐๐ Hume challenges us to look closely, question boldly, and reason with humility โ a timeless guide for scholars, clinicians, and leaders navigating uncertainty. ๐๐ก #Philosophy #Hume...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
The U.S. heart failure landscape is transformingโand fast. ๐ซ๐ A new JACC analysis reveals a 35-year shift from ischemic to metabolic drivers of heart failure, with obesity, dysglycemia, and chronic kidney disease rising sharply, even as blood pressure, cholesterol, smoking, and myocardial infarction decline. ๐โ๏ธ These trends demand a new generation of HF trialsโmore inclusive, prevention-focused, metabolism-centered, and designed to capture outcomes beyond cardiovascular death. ๐๐งฌ A powerful reminder: heart failure is not inevitableโbut the way we...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
๐งฌโณ New Insights into Organ-Specific Aging! ๐ง โค๏ธ๐ฉบ Just explored a remarkable Nature Aging study showing how organ-specific proteomic clocks can forecast disease, cognitive decline, and even longevity with impressive precision. These clocksโbuilt from >2,900 plasma proteinsโreveal that the brain, kidney, and arteries age on their own timelines, each carrying unique clues about future health. What struck me most is how brain aging outperforms traditional risk markers, predicting dementia even after accounting for age, APOE genotype, and cognitive scores. A...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
Respiratory vaccines are not just infection-fightersโtheyโre cardiovascular protectors. ๐๐ซ The 2025 JACC Consensus reminds us that influenza, pneumococcal, COVID-19, RSV, and zoster vaccines reduce MI, HF decompensation, hospitalizations, and death in our most vulnerable patients. As clinicians, we hold the power to translate evidence into prevention: strong recommendations, simple pathways, and clear conversations can save lives long before interventions do. ๐ Vaccinate to protect the heart. Shield to preserve life. Prevent to empower patients. โค๏ธโ๐ฉน ...
info_outline๐จ SOFA-2 arrives โ a thoughtful evolution in critical care scoring ๐ง ๐ซ๐ซ
After nearly 30 years, the SOFA score has been modernized using data from >3.3 million ICU patients across 9 countries. The updated SOFA-2 incorporates contemporary respiratory and cardiovascular supports (HFNC, NIPPV, vasopressors, ECMO) and refines thresholds while preserving simplicity and bedside usability.
A meaningful step forward in describing organ dysfunction โ with room for future biologically grounded refinement.
๐ Published in JAMA